Aurobindo Pharma Has among the list of broadest API portfolios among Indian pharmaceutical companies, with more than 200 APIs. It is a number one global manufacturer of semi-artificial penicillins and maintains a robust presence in anti-retrovirals and cardiovascular APIs. The company’s vertically built-in design supplies substantial cost strengths. It is https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html